Chagas

FEXI 12

Oral fexinidazole dosing regimens for the treatment of adults with chronic indeterminate Chagas disease

Photo: DNDi
Duration
04/10/2017 - 31/12/2018
Coordinator
Joaquim Gascon
Funded by
DNDi

Phase 2 Randomized, Multicenter, Double-blinded Safety and Efficacy Study

The general objective of this clinical trial is to determine the efficacy and safety of alternative dosing regimens of FEXI in reducing and clearing T. cruzi parasitemia in adult individuals with the chronic indeterminate Chagas Disease, in comparison to historical placebo control.

This is  a double-blind, randomized, prospective, comparative, pharmacokineticpharmacodynamic, and proof-of-concept trial design, with three-parallel groups and historical placebo control. The trial will be conducted in 5 different sites in Spain. The trial will be sufficiently powered to compare the efficacy and safety of each of the dosing regimens of FEXI with historical placebo control. Efficacy and safety will be monitored by an external independent Data Monitoring Committee (DMC) on an ongoing basis. The committee is to include cardiac and liver safety experts, as well as Chagas Disease clinical expertise.

The total duration of patient trial participation will be approximately 14 months.

Our Team

PI

  • Joaquim Gascon
    Joaquim Gascon Research Professor, Director of the Chagas Initiative, head of the Chagas, Parasitic and Imported Diseases programme

ISGlobal team

See More

Other projects

See Past Projects

NHEPACHA

New Tools for the Diagnosis and Evaluation of Chagas Disease

Euroleish.net

Control of Leishmaniasis. From bench to bedside and community

GREPIMER

Grup de recerca en patología importada i malaties emergents i re-emergents

TcONTROL

Antigen-specific immunological biomarkers associated to control of infection by T. cruzi.

Xtrategy

Model and Tool for designing strategies to scale up Chagas Disease care

STOP

Towards the interruption of transmission of soil-transmitted helminths

TESEO

New chemotherapy regimens and biomarkers for Chagas Disease

AVATAR

Searching the hidden: evaluating dengue, chikungunya and Zika autochthonous transmission in the city of Barcelona.